Antidiabetic action of nateglinide includes augmentation of glucagon-like peptide-1 activity mediated partly through inhibition of DPP IV mediated degradation

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)0882
Issue numberSuppl.
Publication statusPublished (in print/issue) - Sept 2007

Bibliographical note

43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Amsterdam, NETHERLANDS,
SEP 18-21, 2007

Cite this